Immunopharmacology

Warning: Undefined array key "S1" in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immunopharmacology.php on line 2
Immunopharmacology

LE WE PMID CA

Immunopharmacology

5165

Immunpharmakologie

3 HMG CoA reductase

Adenosine

Autoimmunity

BG 12

BTLA

Cannabis

CD160

CD4

Chaperone

Cladribine

Complement system

Fingolimod

HVEM

Immunopharmacology

Interfering diseases

Laquinimod

LIGHT

MTOR

Multiple sclerosis

Mycobacterium (BASKET)

Natural products

Procyanidins

Receptor (Aromatic hydrocarbon)

Redox (BASKET)

RelB

Statin

Stem cell (BASKET)

T cell (gammadelta)

T cell (Th17)

Tamoxifen

Tannin

Teriflunomide

Vasoactive intestinal peptide

Vitamin D

2003 1	Alerting and tuning the immune response by extracellular nucleotides. [12629147] J Leukoc Biol 73(3): 339-43 (2003)
2002 2	Treatments no longer in development for rheumatoid arthritis. [12379620] Ann Rheum Dis 61 Suppl 2(-): ii43-5 (2002)
2007 3	The use of stem cells for the treatment of autoimmune diseases. [17713674] Braz J Med Biol Res 40(12): 1579-97 (2007)
2010 4	Molecular chaperones and protein-folding catalysts as intercellular signaling regulators in immunity and inflammation. [20445014] J Leukoc Biol 88(3): 445-62 (2010)
2010 5	HVEM/LIGHT/BTLA/CD160 cosignaling pathways as targets for immune regulation. [20007250] J Leukoc Biol 87(2): 223-35 (2010)
2003 6	Specific CD4 down-modulating compounds with potent anti-HIV activity. [12960237] J Leukoc Biol 74(5): 667-75 (2003)
2008 7	Synthetic oligonucleotides as modulators of inflammation. [18430787] J Leukoc Biol 84(4): 958-64 (2008)
2010 8	The therapeutic potential of the filarial nematode-derived immunodulator, ES-62 in inflammatory disease. [19968663] Clin Exp Immunol 159(3): 256-67 (2010)
2009 9	Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease. [19604262] Clin Exp Immunol 157(2): 225-34 (2009)
2009 10	Immunoregulatory functions of mTOR inhibition. [19390566] Nat Rev Immunol 9(5): 324-37 (2009)
2009 11	The adenosinergic immunomodulatory drugs. [19539527] Curr Opin Pharmacol 9(4): 501-6 (2009)
2009 12	Identification of novel immunosuppressive pathways paves the way for drug discovery. [19625216] Curr Opin Pharmacol 9(4): 445-6 (2009)
2009 13	Regulation of different inflammatory diseases by impacting the mevalonate pathway. [19191903] Immunology 127(1): 18-25 (2009)
2009 14	The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. [19538249] Immunology 127(3): 299-311 (2009)
2004 15	Topical immunomodulators in dermatology. [15235214] J Postgrad Med 50(2): 131-9 (2004)
2007 16	Vitamin D receptor-mediated suppression of RelB in antigen presenting cells: a paradigm for ligand-augmented negative transcriptional regulation. [17367745] Arch Biochem Biophys 460(2): 218-26 (2007)
2011 17	Development of oral immunomodulatory agents in the management of multiple sclerosis. [21625416] Drug Des Devel Ther 5(-): 255-74 (2011)
2009 18	The aryl hydrocarbon receptor is a modulator of anti-viral immunity. [19027719] Biochem Pharmacol 77(4): 642-53 (2009)
2009 19	AHR-mediated immunomodulation: the role of altered gene transcription. [19100241] Biochem Pharmacol 77(4): 746-60 (2009)
2009 20	The effects of tamoxifen on immunity. [19689284] Curr Med Chem 16(24): 3076-80 (2009)
2010 21	Do cannabinoids have a therapeutic role in transplantation? [20591510] Trends Pharmacol Sci 31(8): 345-50 (2010)
2002 22	Immune-based therapies: a review of clinical endpoints used in trials of selected immunologic agents. [11819187] HIV Clin Trials 3(1): 58-88 (2002)
2008 23	Antigen-specific tolerogenic and immunomodulatory strategies for the treatment of autoimmune arthritis. [18177689] Semin Arthritis Rheum 38(3): 195-207 (2008)
2010 24	The emergence of immunomodulation: combinatorial immunochemotherapy opportunities for the next decade. [19959212] Gynecol Oncol 116(2): 222-33 (2010)
2010 25	Mycobacteria-induced suppression of autoimmunity in the central nervous system. [20333556] J Neuroimmune Pharmacol 5(2): 210-9 (2010)
2010 26	Redox remodeling as an immunoregulatory strategy. [20070126] Biochemistry 49(6): 1059-66 (2010)
2008 27	Response of gammadelta T Cells to plant-derived tannins. [19166386] Crit Rev Immunol 28(5): 377-402 (2008)
2009 28	Recent developments in low molecular weight complement inhibitors. [19800693] Mol Immunol 47(2-3): 185-95 (2009)
2011 29	Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. [21762539] J Biomed Sci 18(-): 49 (2011)
2007 30	Tuning immune tolerance with vasoactive intestinal peptide: a new therapeutic approach for immune disorders. [17521775] Peptides 28(9): 1833-46 (2007)
2008 31	The immunopharmaceutical effects and mechanisms of herb medicine. [18318991] Cell Mol Immunol 5(1): 23-31 (2008)
2010 32	Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression. [19457575] Immunobiology 215(8): 598-605 (2010)
2010 33	Development of antibody surrogates for the treatment of cancers and autoimmune disease. [20674470] Curr Opin Chem Biol 14(6): 721-7 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immunopharmacology.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Immunopharmacology.php on line 92